Bulletin
Investor Alert

New York Markets After Hours

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Real time quotes

Jan 25, 2022, 5:30 p.m.

/zigman2/quotes/207821052/composite

$

89.35

Change

+4.58 +5.40%

Volume

Volume 86,542

Real time quotes

/zigman2/quotes/207821052/composite

Today's close

$ 88.21

$ 84.77

Change

-3.44 -3.90%

Day low

Day high

$81.33

$90.02

Open

52 week low

52 week high

$43.86

$202.73

Open

Annual Financials for Intellia Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 16.48M26.12M30.43M43.1M57.99M
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense 1.1M2.99M4.46M5.59M6.31M
Depreciation 1.1M2.99M4.46M5.59M6.31M
Amortization of Intangibles -----
Gross Income -----
20162017201820192020 5-year trend
SG&A Expense 47.53M92.68M116.84M143.88M188.27M
Research & Development 31.84M67.65M89.12M108.41M144.1M
Other SG&A 15.69M25.03M27.73M35.47M44.17M
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense -----
Non-Operating Interest Income 525,0002.01M5.53M6.84M2.35M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (31.63M)(67.54M)(85.34M)(99.53M)(134.23M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (31.63M)(67.54M)(85.34M)(99.53M)(134.23M)
Minority Interest Expense -----
Net Income (31.63M)(67.54M)(85.34M)(99.53M)(134.23M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (31.63M)(67.54M)(85.34M)(99.53M)(134.23M)
Preferred Dividends -----
Net Income Available to Common (31.63M)(67.54M)(85.34M)(99.53M)(134.23M)
EPS (Basic) (1.42)(1.88)(1.98)(2.11)(2.40)
Basic Shares Outstanding 22.22M36.01M43.07M47.25M55.99M
EPS (Diluted) (1.42)(1.88)(1.98)(2.11)(2.40)
Diluted Shares Outstanding 22.22M36.01M43.07M47.25M55.99M
EBITDA (31.06M)(66.56M)(86.41M)(100.78M)(130.27M)
Trending Tickers
  • /zigman2/quotes/208747069/composite GEVO+7.77%
  • /zigman2/quotes/228313454/composite CNTX+0.36%
  • /zigman2/quotes/214140886/composite CHPT+5.01%
  • /zigman2/quotes/208173073/composite SFIX+4.61%
  • /zigman2/quotes/222642382/composite OLMA+5.43%
X
Powered by StockTwits
Link to MarketWatch's Slice.